 Catherine Flaitz
Concepts (788)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dental Caries | 58 | 2017 | 173 | 4.210 |
Why?
| | Mouth Diseases | 21 | 2018 | 46 | 2.810 |
Why?
| | Mouth Neoplasms | 23 | 2012 | 90 | 2.070 |
Why?
| | Diagnosis, Differential | 61 | 2025 | 1495 | 2.040 |
Why?
| | Cariostatic Agents | 23 | 2014 | 32 | 1.970 |
Why?
| | Dental Cementum | 4 | 2025 | 11 | 1.880 |
Why?
| | Fluorides | 23 | 2014 | 49 | 1.770 |
Why?
| | Gingival Diseases | 12 | 2012 | 19 | 1.640 |
Why?
| | Dental Enamel | 32 | 2007 | 67 | 1.550 |
Why?
| | Mouth Mucosa | 21 | 2014 | 88 | 1.290 |
Why?
| | Tongue Neoplasms | 5 | 2013 | 25 | 1.270 |
Why?
| | Dental Restoration, Permanent | 12 | 2003 | 43 | 1.180 |
Why?
| | Incisor | 5 | 2025 | 22 | 1.170 |
Why?
| | Mandibular Neoplasms | 13 | 2003 | 22 | 1.040 |
Why?
| | Tooth Abnormalities | 3 | 2026 | 16 | 1.030 |
Why?
| | Tooth Injuries | 3 | 2025 | 9 | 0.960 |
Why?
| | Precancerous Conditions | 6 | 2013 | 166 | 0.940 |
Why?
| | Tooth, Supernumerary | 2 | 2025 | 5 | 0.940 |
Why?
| | AIDS-Related Opportunistic Infections | 15 | 2005 | 130 | 0.900 |
Why?
| | Tooth, Deciduous | 12 | 2006 | 19 | 0.870 |
Why?
| | Tooth Remineralization | 8 | 2007 | 12 | 0.860 |
Why?
| | Carcinoma, Squamous Cell | 11 | 2013 | 642 | 0.860 |
Why?
| | Lip Diseases | 6 | 2013 | 7 | 0.860 |
Why?
| | Ethics, Dental | 3 | 2013 | 3 | 0.830 |
Why?
| | Molar | 22 | 2014 | 47 | 0.820 |
Why?
| | Mandibular Diseases | 7 | 2007 | 11 | 0.820 |
Why?
| | Pit and Fissure Sealants | 10 | 2007 | 19 | 0.820 |
Why?
| | Lichen Planus, Oral | 4 | 2013 | 5 | 0.820 |
Why?
| | Humans | 231 | 2026 | 144957 | 0.690 |
Why?
| | Tooth Root | 11 | 2026 | 21 | 0.680 |
Why?
| | Gingival Neoplasms | 5 | 2001 | 10 | 0.660 |
Why?
| | HIV Infections | 31 | 2013 | 3154 | 0.640 |
Why?
| | Gingiva | 4 | 2012 | 25 | 0.620 |
Why?
| | Condylomata Acuminata | 3 | 2013 | 7 | 0.600 |
Why?
| | Child | 59 | 2026 | 22657 | 0.590 |
Why?
| | Composite Resins | 10 | 2010 | 106 | 0.570 |
Why?
| | Odontogenic Tumors | 6 | 2001 | 9 | 0.560 |
Why?
| | Glossitis | 3 | 2003 | 3 | 0.530 |
Why?
| | Burns, Chemical | 2 | 2012 | 32 | 0.520 |
Why?
| | Fluorides, Topical | 9 | 2004 | 16 | 0.510 |
Why?
| | Sarcoma, Kaposi | 8 | 2002 | 83 | 0.490 |
Why?
| | Male | 95 | 2026 | 72406 | 0.490 |
Why?
| | Drugs, Chinese Herbal | 1 | 2016 | 24 | 0.470 |
Why?
| | Resin Cements | 8 | 2010 | 24 | 0.470 |
Why?
| | Tongue | 7 | 2004 | 76 | 0.460 |
Why?
| | Candidiasis, Oral | 13 | 2007 | 19 | 0.450 |
Why?
| | Saliva | 8 | 2003 | 249 | 0.440 |
Why?
| | Laser Therapy | 12 | 2006 | 135 | 0.430 |
Why?
| | Maxillary Diseases | 4 | 2012 | 7 | 0.430 |
Why?
| | Radiography | 19 | 2007 | 845 | 0.430 |
Why?
| | Acidulated Phosphate Fluoride | 12 | 2007 | 12 | 0.430 |
Why?
| | Dental Bonding | 6 | 2010 | 28 | 0.420 |
Why?
| | Dental Sac | 1 | 2014 | 1 | 0.420 |
Why?
| | Gingival Hypertrophy | 1 | 2014 | 1 | 0.420 |
Why?
| | Analysis of Variance | 24 | 2007 | 1311 | 0.420 |
Why?
| | Root Caries | 9 | 2014 | 10 | 0.400 |
Why?
| | Mouth Floor | 4 | 2001 | 7 | 0.400 |
Why?
| | Herpesvirus 4, Human | 9 | 2007 | 176 | 0.400 |
Why?
| | Dental Plaque | 6 | 2004 | 19 | 0.400 |
Why?
| | Child, Preschool | 33 | 2026 | 11799 | 0.400 |
Why?
| | Female | 78 | 2026 | 78376 | 0.390 |
Why?
| | Microscopy, Polarization | 17 | 2013 | 31 | 0.390 |
Why?
| | Granular Cell Tumor | 2 | 2003 | 8 | 0.380 |
Why?
| | Lasers | 7 | 2004 | 132 | 0.380 |
Why?
| | Mandible | 6 | 2026 | 72 | 0.380 |
Why?
| | Carcinoma, Mucoepidermoid | 4 | 2000 | 17 | 0.380 |
Why?
| | Oral Ulcer | 8 | 2003 | 11 | 0.370 |
Why?
| | Glass Ionomer Cements | 6 | 2003 | 8 | 0.370 |
Why?
| | Salivary Gland Neoplasms | 4 | 2000 | 39 | 0.370 |
Why?
| | Odontogenic Cysts | 1 | 2012 | 1 | 0.370 |
Why?
| | Dentifrices | 3 | 2014 | 5 | 0.360 |
Why?
| | Purpura | 1 | 2012 | 18 | 0.360 |
Why?
| | Leukoplakia, Hairy | 8 | 2004 | 8 | 0.360 |
Why?
| | Ethics, Professional | 1 | 2011 | 14 | 0.350 |
Why?
| | Head and Neck Neoplasms | 4 | 2002 | 562 | 0.350 |
Why?
| | Jaw Diseases | 2 | 2005 | 5 | 0.350 |
Why?
| | Gingivitis | 2 | 2010 | 13 | 0.340 |
Why?
| | Tooth Diseases | 2 | 2001 | 13 | 0.340 |
Why?
| | Palatal Neoplasms | 2 | 2001 | 6 | 0.340 |
Why?
| | Gingival Hyperplasia | 1 | 2010 | 3 | 0.340 |
Why?
| | Cheek | 2 | 2000 | 16 | 0.320 |
Why?
| | Dental Cavity Preparation | 7 | 2003 | 7 | 0.320 |
Why?
| | Gingivitis, Necrotizing Ulcerative | 5 | 2003 | 5 | 0.320 |
Why?
| | Sodium Fluoride | 8 | 2013 | 15 | 0.320 |
Why?
| | HIV Seropositivity | 4 | 2007 | 119 | 0.320 |
Why?
| | Lithiasis | 1 | 2009 | 3 | 0.310 |
Why?
| | Fibroma, Ossifying | 3 | 2001 | 3 | 0.310 |
Why?
| | Tooth Eruption | 5 | 2014 | 10 | 0.310 |
Why?
| | Pharyngeal Diseases | 1 | 2009 | 16 | 0.310 |
Why?
| | Schools, Dental | 2 | 2011 | 14 | 0.310 |
Why?
| | Leukoplakia, Oral | 3 | 2011 | 9 | 0.310 |
Why?
| | Palatine Tonsil | 1 | 2009 | 55 | 0.300 |
Why?
| | Teaching | 1 | 2011 | 236 | 0.290 |
Why?
| | Cysts | 3 | 2002 | 111 | 0.290 |
Why?
| | Academic Medical Centers | 2 | 2011 | 548 | 0.280 |
Why?
| | Glossitis, Benign Migratory | 3 | 2010 | 5 | 0.280 |
Why?
| | Immunocompromised Host | 6 | 2013 | 201 | 0.280 |
Why?
| | Anesthesia, Dental | 5 | 2014 | 22 | 0.280 |
Why?
| | Alveolar Bone Loss | 2 | 2007 | 9 | 0.280 |
Why?
| | Adult | 55 | 2013 | 40506 | 0.280 |
Why?
| | Stomatitis, Herpetic | 4 | 2001 | 5 | 0.270 |
Why?
| | Epithelium | 9 | 2012 | 314 | 0.270 |
Why?
| | Acyclovir | 6 | 2004 | 96 | 0.270 |
Why?
| | Histiocytosis, Langerhans-Cell | 2 | 2005 | 36 | 0.270 |
Why?
| | Salivary Gland Calculi | 2 | 2000 | 3 | 0.270 |
Why?
| | Dental Care for Chronically Ill | 5 | 2006 | 10 | 0.270 |
Why?
| | Dental Materials | 3 | 2003 | 56 | 0.270 |
Why?
| | Tooth Demineralization | 8 | 2013 | 10 | 0.270 |
Why?
| | Acquired Immunodeficiency Syndrome | 4 | 2001 | 235 | 0.260 |
Why?
| | Acid Etching, Dental | 7 | 2001 | 12 | 0.260 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2011 | 339 | 0.260 |
Why?
| | Tooth Extraction | 3 | 2025 | 28 | 0.260 |
Why?
| | Denture, Complete, Lower | 1 | 2007 | 1 | 0.260 |
Why?
| | Dental Implantation, Endosseous | 1 | 2007 | 3 | 0.260 |
Why?
| | Dental Prosthesis, Implant-Supported | 1 | 2007 | 7 | 0.250 |
Why?
| | Zirconium | 3 | 2001 | 11 | 0.250 |
Why?
| | Maxillary Neoplasms | 4 | 1995 | 8 | 0.250 |
Why?
| | Learning | 1 | 2011 | 452 | 0.250 |
Why?
| | Dental Implants | 1 | 2007 | 10 | 0.250 |
Why?
| | Gingival Overgrowth | 3 | 2003 | 5 | 0.250 |
Why?
| | Middle Aged | 41 | 2013 | 35928 | 0.250 |
Why?
| | Papillomavirus Infections | 3 | 2013 | 345 | 0.250 |
Why?
| | Valine | 5 | 2004 | 80 | 0.250 |
Why?
| | Saliva, Artificial | 9 | 2014 | 11 | 0.250 |
Why?
| | Dentists | 3 | 2001 | 21 | 0.240 |
Why?
| | Tooth, Unerupted | 2 | 2002 | 2 | 0.240 |
Why?
| | Biopsy | 8 | 2012 | 1077 | 0.240 |
Why?
| | Tooth, Impacted | 3 | 2003 | 8 | 0.240 |
Why?
| | Adolescent | 31 | 2025 | 22453 | 0.240 |
Why?
| | Radiography, Panoramic | 1 | 2026 | 14 | 0.240 |
Why?
| | Dental Enamel Solubility | 5 | 2006 | 5 | 0.240 |
Why?
| | Maxilla | 7 | 2002 | 36 | 0.240 |
Why?
| | Texas | 8 | 2017 | 278 | 0.230 |
Why?
| | Tooth Fractures | 1 | 2025 | 7 | 0.230 |
Why?
| | Epstein-Barr Virus Infections | 5 | 2007 | 101 | 0.230 |
Why?
| | Molluscum Contagiosum | 2 | 2002 | 4 | 0.230 |
Why?
| | Sarcoidosis | 1 | 2007 | 160 | 0.230 |
Why?
| | Silicon Dioxide | 3 | 2001 | 121 | 0.230 |
Why?
| | Dental Caries Susceptibility | 11 | 2006 | 11 | 0.230 |
Why?
| | Dental Research | 1 | 2005 | 4 | 0.220 |
Why?
| | Tuberculosis, Lymph Node | 1 | 2005 | 7 | 0.220 |
Why?
| | Odontoma | 2 | 2003 | 4 | 0.220 |
Why?
| | Cuspid | 2 | 2002 | 9 | 0.220 |
Why?
| | Cytodiagnosis | 4 | 2012 | 31 | 0.220 |
Why?
| | Dentist-Patient Relations | 3 | 2013 | 6 | 0.220 |
Why?
| | Microscopy, Electron, Scanning | 15 | 2003 | 199 | 0.220 |
Why?
| | Blister | 2 | 2001 | 39 | 0.220 |
Why?
| | Lymphocele | 1 | 2004 | 2 | 0.210 |
Why?
| | Compomers | 2 | 2003 | 2 | 0.210 |
Why?
| | Tongue Diseases | 1 | 2004 | 9 | 0.210 |
Why?
| | Mucocele | 2 | 2001 | 12 | 0.210 |
Why?
| | Hemangioma | 2 | 2002 | 46 | 0.210 |
Why?
| | Calcium Phosphates | 2 | 2004 | 28 | 0.210 |
Why?
| | Warts | 2 | 2001 | 6 | 0.210 |
Why?
| | Root Resorption | 3 | 2006 | 4 | 0.200 |
Why?
| | Lymphoma, AIDS-Related | 2 | 2002 | 14 | 0.200 |
Why?
| | Calcium | 5 | 2007 | 1184 | 0.200 |
Why?
| | Prevalence | 7 | 2026 | 2836 | 0.200 |
Why?
| | Argon | 16 | 2004 | 21 | 0.200 |
Why?
| | Hyperplasia | 5 | 2003 | 174 | 0.200 |
Why?
| | Lymphatic Diseases | 2 | 2002 | 20 | 0.200 |
Why?
| | Granuloma, Giant Cell | 2 | 2000 | 4 | 0.200 |
Why?
| | Erythema | 2 | 2001 | 28 | 0.200 |
Why?
| | Bites, Human | 2 | 2014 | 3 | 0.190 |
Why?
| | Dental Amalgam | 1 | 2002 | 2 | 0.190 |
Why?
| | Prognosis | 12 | 2002 | 4293 | 0.190 |
Why?
| | Cytomegalovirus Infections | 2 | 1996 | 206 | 0.190 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 2002 | 6 | 0.190 |
Why?
| | Follow-Up Studies | 7 | 2025 | 5417 | 0.180 |
Why?
| | Universities | 1 | 2005 | 452 | 0.180 |
Why?
| | Parotitis | 2 | 2003 | 6 | 0.180 |
Why?
| | Lip Neoplasms | 1 | 2002 | 2 | 0.180 |
Why?
| | Crowns | 1 | 2002 | 2 | 0.180 |
Why?
| | Germinal Center | 1 | 2002 | 67 | 0.180 |
Why?
| | Cheilitis | 2 | 2003 | 3 | 0.180 |
Why?
| | Toothpastes | 2 | 2000 | 6 | 0.180 |
Why?
| | Sialadenitis | 1 | 2001 | 1 | 0.180 |
Why?
| | Sublingual Gland | 1 | 2001 | 1 | 0.180 |
Why?
| | Disease Progression | 6 | 2013 | 2852 | 0.180 |
Why?
| | Personal Autonomy | 2 | 2013 | 59 | 0.180 |
Why?
| | Cyclosporine | 1 | 2003 | 265 | 0.180 |
Why?
| | Salivary Glands, Minor | 2 | 2000 | 10 | 0.180 |
Why?
| | Nevus, Blue | 1 | 2001 | 2 | 0.170 |
Why?
| | Diazepam | 3 | 1986 | 33 | 0.170 |
Why?
| | Rhabdomyosarcoma | 1 | 2002 | 64 | 0.170 |
Why?
| | Evidence-Based Dentistry | 2 | 2012 | 6 | 0.170 |
Why?
| | Fibroma | 1 | 2001 | 20 | 0.170 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2013 | 278 | 0.170 |
Why?
| | Pediatric Dentistry | 3 | 2001 | 12 | 0.170 |
Why?
| | Light | 6 | 2012 | 411 | 0.170 |
Why?
| | Durapatite | 2 | 2004 | 36 | 0.170 |
Why?
| | Hair Dyes | 1 | 2000 | 3 | 0.170 |
Why?
| | Lip | 2 | 2000 | 22 | 0.170 |
Why?
| | Sjogren's Syndrome | 1 | 2001 | 37 | 0.170 |
Why?
| | Burkitt Lymphoma | 1 | 2001 | 62 | 0.160 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 847 | 0.160 |
Why?
| | Dental Care for Children | 2 | 1999 | 12 | 0.160 |
Why?
| | Neuroma | 1 | 2000 | 5 | 0.160 |
Why?
| | Resins, Synthetic | 1 | 2000 | 14 | 0.160 |
Why?
| | Neoplasms, Second Primary | 1 | 2002 | 100 | 0.160 |
Why?
| | Malpractice | 1 | 2001 | 44 | 0.160 |
Why?
| | Candida | 4 | 2006 | 44 | 0.160 |
Why?
| | Palate, Hard | 1 | 2000 | 5 | 0.160 |
Why?
| | Sunlight | 1 | 2001 | 78 | 0.160 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2001 | 99 | 0.160 |
Why?
| | Focal Epithelial Hyperplasia | 1 | 2000 | 1 | 0.160 |
Why?
| | Lymphangioma | 1 | 2000 | 9 | 0.160 |
Why?
| | Calcinosis | 1 | 2002 | 234 | 0.160 |
Why?
| | Lipoma | 1 | 2000 | 17 | 0.160 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2000 | 49 | 0.160 |
Why?
| | Herpesvirus 8, Human | 2 | 1997 | 68 | 0.150 |
Why?
| | Mineral Waters | 2 | 1989 | 2 | 0.150 |
Why?
| | Child Behavior | 3 | 2014 | 236 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2011 | 1141 | 0.150 |
Why?
| | Virus Replication | 6 | 2007 | 529 | 0.150 |
Why?
| | Food Hypersensitivity | 1 | 2001 | 164 | 0.150 |
Why?
| | Biomarkers, Tumor | 4 | 2004 | 1322 | 0.150 |
Why?
| | Candidiasis | 1 | 1999 | 64 | 0.150 |
Why?
| | Oncogenic Viruses | 1 | 1998 | 3 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2014 | 561 | 0.140 |
Why?
| | Attitude to Health | 2 | 2013 | 436 | 0.140 |
Why?
| | Vinblastine | 3 | 1995 | 75 | 0.140 |
Why?
| | Surface Properties | 8 | 2003 | 410 | 0.140 |
Why?
| | Self-Injurious Behavior | 1 | 2000 | 142 | 0.140 |
Why?
| | Facial Dermatoses | 3 | 2008 | 17 | 0.140 |
Why?
| | Statistics, Nonparametric | 7 | 2007 | 427 | 0.140 |
Why?
| | Dens in Dente | 2 | 1990 | 2 | 0.140 |
Why?
| | Osteoradionecrosis | 1 | 1998 | 4 | 0.140 |
Why?
| | Recurrence | 6 | 2003 | 1135 | 0.140 |
Why?
| | Nose Diseases | 1 | 1998 | 17 | 0.140 |
Why?
| | Pulpotomy | 2 | 1989 | 3 | 0.130 |
Why?
| | Myxoma | 1 | 1997 | 11 | 0.130 |
Why?
| | Palate | 1 | 1998 | 39 | 0.130 |
Why?
| | X-Ray Film | 2 | 1987 | 5 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2013 | 1721 | 0.130 |
Why?
| | Periodontal Diseases | 3 | 2007 | 62 | 0.130 |
Why?
| | Bicuspid | 5 | 2001 | 14 | 0.130 |
Why?
| | Dentin-Bonding Agents | 4 | 2003 | 14 | 0.130 |
Why?
| | Taste Buds | 1 | 1999 | 212 | 0.120 |
Why?
| | Cleft Lip | 1 | 2017 | 72 | 0.120 |
Why?
| | Specimen Handling | 1 | 1998 | 186 | 0.120 |
Why?
| | Xylitol | 2 | 2014 | 4 | 0.120 |
Why?
| | Tooth Bleaching | 1 | 1996 | 3 | 0.120 |
Why?
| | Peroxides | 1 | 1996 | 19 | 0.120 |
Why?
| | Melanoma | 2 | 2000 | 761 | 0.120 |
Why?
| | Cleft Palate | 1 | 2017 | 89 | 0.120 |
Why?
| | Cooperative Behavior | 4 | 2011 | 465 | 0.120 |
Why?
| | Ameloblastoma | 2 | 1993 | 5 | 0.120 |
Why?
| | Acids | 2 | 2012 | 17 | 0.120 |
Why?
| | Chronic Disease | 2 | 2018 | 1813 | 0.120 |
Why?
| | Ulcer | 1 | 1996 | 37 | 0.120 |
Why?
| | Anesthesia, Rectal | 2 | 1985 | 2 | 0.120 |
Why?
| | Secondary Prevention | 3 | 2002 | 255 | 0.120 |
Why?
| | Langerhans Cells | 2 | 2007 | 12 | 0.120 |
Why?
| | Urea | 1 | 1996 | 84 | 0.120 |
Why?
| | Cross-Sectional Studies | 3 | 2026 | 5872 | 0.120 |
Why?
| | HIV Seronegativity | 4 | 2007 | 29 | 0.120 |
Why?
| | Jaw Neoplasms | 1 | 1995 | 3 | 0.120 |
Why?
| | Acculturation | 1 | 2016 | 54 | 0.110 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 1995 | 7 | 0.110 |
Why?
| | Retrospective Studies | 9 | 2026 | 17101 | 0.110 |
Why?
| | Statistics as Topic | 5 | 2001 | 284 | 0.110 |
Why?
| | Osteomyelitis | 2 | 2000 | 143 | 0.110 |
Why?
| | Age Factors | 6 | 2016 | 3335 | 0.110 |
Why?
| | Sex Factors | 4 | 2016 | 2114 | 0.110 |
Why?
| | Orthodontic Brackets | 3 | 2010 | 15 | 0.110 |
Why?
| | Infant | 11 | 2002 | 10039 | 0.110 |
Why?
| | Phosphates | 4 | 2013 | 180 | 0.110 |
Why?
| | Tooth Eruption, Ectopic | 2 | 2003 | 2 | 0.110 |
Why?
| | Gingival Hemorrhage | 1 | 2014 | 1 | 0.100 |
Why?
| | Hernia | 1 | 2014 | 10 | 0.100 |
Why?
| | Apatites | 2 | 2004 | 4 | 0.100 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 3 | 2000 | 53 | 0.100 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 1995 | 177 | 0.100 |
Why?
| | Diastema | 1 | 1993 | 3 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2001 | 847 | 0.100 |
Why?
| | Fat Necrosis | 1 | 1993 | 10 | 0.100 |
Why?
| | Hypercalcemia | 1 | 1993 | 22 | 0.100 |
Why?
| | Papillomaviridae | 3 | 2000 | 115 | 0.100 |
Why?
| | Risk Factors | 10 | 2018 | 10792 | 0.100 |
Why?
| | Epithelial Cells | 4 | 2007 | 1126 | 0.100 |
Why?
| | Aurothioglucose | 1 | 1993 | 3 | 0.100 |
Why?
| | Lichen Planus | 1 | 1993 | 3 | 0.100 |
Why?
| | Chromosome Aberrations | 2 | 2005 | 163 | 0.100 |
Why?
| | Thermodynamics | 5 | 2001 | 426 | 0.100 |
Why?
| | Keratosis | 2 | 2003 | 16 | 0.090 |
Why?
| | Human papillomavirus 16 | 1 | 2013 | 27 | 0.090 |
Why?
| | Low-Level Light Therapy | 2 | 2004 | 7 | 0.090 |
Why?
| | Acrylic Resins | 3 | 2007 | 45 | 0.090 |
Why?
| | DMF Index | 5 | 2003 | 18 | 0.090 |
Why?
| | Antiviral Agents | 6 | 2004 | 768 | 0.090 |
Why?
| | Mass Screening | 2 | 2012 | 1348 | 0.090 |
Why?
| | Cariogenic Agents | 2 | 2014 | 2 | 0.090 |
Why?
| | Hypnotics and Sedatives | 1 | 2014 | 216 | 0.090 |
Why?
| | Tooth Erosion | 1 | 2012 | 3 | 0.090 |
Why?
| | Candy | 1 | 2012 | 5 | 0.090 |
Why?
| | Wound Healing | 2 | 2005 | 351 | 0.090 |
Why?
| | Dentin | 5 | 2001 | 22 | 0.090 |
Why?
| | Moral Development | 1 | 2011 | 2 | 0.090 |
Why?
| | Adolescent Behavior | 2 | 2002 | 501 | 0.090 |
Why?
| | Schools, Health Occupations | 1 | 2011 | 8 | 0.090 |
Why?
| | Simplexvirus | 3 | 1998 | 82 | 0.090 |
Why?
| | Curriculum | 2 | 2011 | 1060 | 0.090 |
Why?
| | Dental Hygienists | 1 | 2011 | 14 | 0.090 |
Why?
| | Administrative Personnel | 1 | 2011 | 33 | 0.090 |
Why?
| | Bioethical Issues | 1 | 2011 | 8 | 0.090 |
Why?
| | Keratins | 1 | 2012 | 172 | 0.090 |
Why?
| | Organizational Objectives | 1 | 2011 | 66 | 0.090 |
Why?
| | Dental Cavity Lining | 2 | 2002 | 2 | 0.080 |
Why?
| | General Practice, Dental | 3 | 2006 | 6 | 0.080 |
Why?
| | Dental Alloys | 3 | 2002 | 5 | 0.080 |
Why?
| | Alphapapillomavirus | 1 | 2011 | 35 | 0.080 |
Why?
| | Immunohistochemistry | 5 | 2003 | 1718 | 0.080 |
Why?
| | Stomatitis, Aphthous | 2 | 2001 | 9 | 0.080 |
Why?
| | Granuloma, Pyogenic | 2 | 2001 | 10 | 0.080 |
Why?
| | Staff Development | 1 | 2011 | 61 | 0.080 |
Why?
| | Truth Disclosure | 1 | 2011 | 50 | 0.080 |
Why?
| | Organizational Innovation | 1 | 2011 | 120 | 0.080 |
Why?
| | Professional Competence | 1 | 2011 | 98 | 0.080 |
Why?
| | DNA, Viral | 5 | 2004 | 358 | 0.080 |
Why?
| | Medical History Taking | 1 | 1991 | 117 | 0.080 |
Why?
| | Problem-Based Learning | 1 | 2011 | 98 | 0.080 |
Why?
| | Polyvinyls | 2 | 2007 | 20 | 0.080 |
Why?
| | Orthodontic Appliances | 2 | 2001 | 13 | 0.080 |
Why?
| | Faculty | 1 | 2011 | 149 | 0.080 |
Why?
| | Formocresols | 2 | 1989 | 2 | 0.080 |
Why?
| | Aged | 13 | 2012 | 25947 | 0.080 |
Why?
| | HIV-1 | 1 | 1996 | 896 | 0.080 |
Why?
| | Gingival Recession | 2 | 2007 | 6 | 0.080 |
Why?
| | Quality of Life | 2 | 2013 | 3192 | 0.080 |
Why?
| | Periapical Diseases | 1 | 1989 | 1 | 0.080 |
Why?
| | Pulpectomy | 1 | 1989 | 1 | 0.080 |
Why?
| | Choice Behavior | 1 | 2011 | 178 | 0.080 |
Why?
| | Dental Clinics | 2 | 2001 | 6 | 0.070 |
Why?
| | Collagen | 1 | 2012 | 456 | 0.070 |
Why?
| | Parents | 2 | 2016 | 1403 | 0.070 |
Why?
| | Cell Division | 3 | 2000 | 766 | 0.070 |
Why?
| | Program Development | 1 | 2011 | 370 | 0.070 |
Why?
| | Tin Fluorides | 2 | 1988 | 3 | 0.070 |
Why?
| | Gels | 3 | 2014 | 84 | 0.070 |
Why?
| | Water Supply | 1 | 1989 | 89 | 0.070 |
Why?
| | Proliferating Cell Nuclear Antigen | 2 | 2000 | 49 | 0.070 |
Why?
| | Infant, Newborn | 7 | 2002 | 6434 | 0.070 |
Why?
| | Nevus | 1 | 2008 | 26 | 0.070 |
Why?
| | Photomicrography | 2 | 2000 | 8 | 0.070 |
Why?
| | Hamartoma | 1 | 2008 | 29 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 4 | 2006 | 277 | 0.070 |
Why?
| | Porosity | 3 | 2003 | 96 | 0.070 |
Why?
| | Xerostomia | 3 | 2000 | 13 | 0.070 |
Why?
| | Vaccination | 1 | 1996 | 1423 | 0.070 |
Why?
| | Drug Combinations | 2 | 2001 | 392 | 0.070 |
Why?
| | In Vitro Techniques | 5 | 2002 | 1048 | 0.070 |
Why?
| | Radicular Cyst | 2 | 1998 | 2 | 0.070 |
Why?
| | Dental Restoration Failure | 2 | 2006 | 6 | 0.060 |
Why?
| | Viral Matrix Proteins | 3 | 2004 | 29 | 0.060 |
Why?
| | Denture, Overlay | 1 | 2007 | 6 | 0.060 |
Why?
| | Jaw, Edentulous | 1 | 2007 | 10 | 0.060 |
Why?
| | Dermatitis, Allergic Contact | 2 | 2000 | 72 | 0.060 |
Why?
| | Denture, Complete, Upper | 1 | 2006 | 2 | 0.060 |
Why?
| | Denture Bases | 1 | 2006 | 2 | 0.060 |
Why?
| | Chromium Alloys | 1 | 2006 | 4 | 0.060 |
Why?
| | Bone Marrow Transplantation | 1 | 1988 | 294 | 0.060 |
Why?
| | Tooth Mobility | 2 | 2006 | 5 | 0.060 |
Why?
| | Osseointegration | 1 | 2007 | 60 | 0.060 |
Why?
| | Dental Prophylaxis | 2 | 2003 | 6 | 0.060 |
Why?
| | Dental Cements | 2 | 2002 | 20 | 0.060 |
Why?
| | HIV | 3 | 1998 | 250 | 0.060 |
Why?
| | Practice Patterns, Dentists' | 1 | 2006 | 3 | 0.060 |
Why?
| | Root Canal Therapy | 1 | 2006 | 7 | 0.060 |
Why?
| | Root Canal Irrigants | 1 | 1986 | 3 | 0.060 |
Why?
| | Insurance Claim Reporting | 1 | 2006 | 26 | 0.060 |
Why?
| | Patient Education as Topic | 1 | 2011 | 780 | 0.060 |
Why?
| | Silicon | 1 | 2005 | 22 | 0.060 |
Why?
| | Prospective Studies | 6 | 2014 | 7997 | 0.060 |
Why?
| | Glass | 1 | 2005 | 46 | 0.060 |
Why?
| | Implants, Experimental | 1 | 2005 | 21 | 0.060 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2005 | 17 | 0.060 |
Why?
| | Resins, Plant | 2 | 2002 | 5 | 0.060 |
Why?
| | Regression Analysis | 2 | 2000 | 1003 | 0.060 |
Why?
| | Education, Dental | 1 | 2006 | 35 | 0.060 |
Why?
| | Denture Design | 2 | 2006 | 4 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 60 | 0.060 |
Why?
| | Antigens, CD | 2 | 2002 | 555 | 0.060 |
Why?
| | Biomedical and Dental Materials | 1 | 2005 | 1 | 0.060 |
Why?
| | Neoplasm Staging | 4 | 2010 | 1465 | 0.060 |
Why?
| | Molar, Third | 1 | 1985 | 6 | 0.060 |
Why?
| | Denture, Complete | 1 | 2005 | 7 | 0.060 |
Why?
| | Pathology, Oral | 1 | 2005 | 1 | 0.060 |
Why?
| | Ganciclovir | 2 | 1996 | 53 | 0.060 |
Why?
| | Antifungal Agents | 3 | 2005 | 149 | 0.060 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2000 | 193 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2017 | 3608 | 0.060 |
Why?
| | Malocclusion | 2 | 2001 | 21 | 0.060 |
Why?
| | Romania | 2 | 2003 | 12 | 0.050 |
Why?
| | Cytoplasmic Granules | 1 | 2005 | 74 | 0.050 |
Why?
| | Dental Pulp Necrosis | 2 | 2001 | 2 | 0.050 |
Why?
| | Chemokines, CC | 1 | 2004 | 32 | 0.050 |
Why?
| | Phosphoric Acids | 4 | 2001 | 17 | 0.050 |
Why?
| | Vocabulary, Controlled | 1 | 2005 | 47 | 0.050 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2004 | 12 | 0.050 |
Why?
| | Receptors, CCR5 | 1 | 2004 | 60 | 0.050 |
Why?
| | Osteosarcoma | 2 | 1998 | 76 | 0.050 |
Why?
| | Burning Mouth Syndrome | 2 | 1996 | 5 | 0.050 |
Why?
| | Treatment Outcome | 6 | 2007 | 11695 | 0.050 |
Why?
| | Dental Enamel Permeability | 1 | 2004 | 1 | 0.050 |
Why?
| | Lymphocytes | 2 | 2004 | 382 | 0.050 |
Why?
| | Halitosis | 1 | 2003 | 1 | 0.050 |
Why?
| | Neoplasm Invasiveness | 3 | 2000 | 509 | 0.050 |
Why?
| | Mental Recall | 1 | 1986 | 222 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 94 | 0.050 |
Why?
| | History, 20th Century | 1 | 2005 | 325 | 0.050 |
Why?
| | Acetates | 2 | 2001 | 80 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2002 | 307 | 0.050 |
Why?
| | Sex Distribution | 2 | 2002 | 386 | 0.050 |
Why?
| | Memory | 1 | 1986 | 296 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2004 | 781 | 0.050 |
Why?
| | Materials Testing | 4 | 2013 | 354 | 0.050 |
Why?
| | Lactobacillus | 1 | 2003 | 28 | 0.050 |
Why?
| | Streptococcus mutans | 1 | 2003 | 8 | 0.050 |
Why?
| | Lymphoma, B-Cell | 1 | 2004 | 132 | 0.050 |
Why?
| | Diet, Cariogenic | 1 | 2003 | 1 | 0.050 |
Why?
| | Secretory Rate | 1 | 2003 | 12 | 0.050 |
Why?
| | Connexins | 1 | 2003 | 56 | 0.050 |
Why?
| | Dental Leakage | 1 | 2002 | 2 | 0.050 |
Why?
| | Methacrylates | 2 | 2000 | 119 | 0.050 |
Why?
| | Reed-Sternberg Cells | 1 | 2002 | 3 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2003 | 73 | 0.050 |
Why?
| | Factor XIIa | 1 | 2002 | 2 | 0.050 |
Why?
| | S100 Proteins | 1 | 2002 | 36 | 0.050 |
Why?
| | Mouthwashes | 3 | 2010 | 13 | 0.050 |
Why?
| | Mentors | 1 | 2005 | 219 | 0.050 |
Why?
| | Polymerase Chain Reaction | 4 | 2003 | 1054 | 0.050 |
Why?
| | Drug Resistance, Viral | 1 | 2003 | 123 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2011 | 1153 | 0.050 |
Why?
| | Stem Cells | 1 | 2007 | 627 | 0.050 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 65 | 0.050 |
Why?
| | Gold Alloys | 1 | 2002 | 1 | 0.050 |
Why?
| | Lymphoma, Follicular | 1 | 2002 | 56 | 0.050 |
Why?
| | Decision Trees | 1 | 2002 | 81 | 0.050 |
Why?
| | Remission Induction | 1 | 2003 | 308 | 0.050 |
Why?
| | Cleidocranial Dysplasia | 1 | 2001 | 1 | 0.040 |
Why?
| | Cosmetic Techniques | 1 | 2002 | 13 | 0.040 |
Why?
| | Combined Modality Therapy | 4 | 2004 | 1268 | 0.040 |
Why?
| | Sclerosis | 1 | 2001 | 11 | 0.040 |
Why?
| | Skin Diseases | 1 | 2003 | 149 | 0.040 |
Why?
| | Dental Service, Hospital | 1 | 2001 | 1 | 0.040 |
Why?
| | Lactic Acid | 2 | 2014 | 302 | 0.040 |
Why?
| | Pericoronitis | 1 | 2001 | 1 | 0.040 |
Why?
| | Respiratory System Abnormalities | 1 | 2001 | 18 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2003 | 340 | 0.040 |
Why?
| | Microfilament Proteins | 1 | 2002 | 136 | 0.040 |
Why?
| | Caustics | 1 | 2001 | 6 | 0.040 |
Why?
| | Heart | 1 | 1985 | 636 | 0.040 |
Why?
| | 2-Propanol | 1 | 2001 | 20 | 0.040 |
Why?
| | Hypoparathyroidism | 1 | 1981 | 7 | 0.040 |
Why?
| | Dental Enamel Hypoplasia | 1 | 1981 | 9 | 0.040 |
Why?
| | Carcinoma, Verrucous | 1 | 2001 | 3 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2005 | 435 | 0.040 |
Why?
| | Dental High-Speed Equipment | 1 | 2001 | 1 | 0.040 |
Why?
| | alpha 1-Antitrypsin | 1 | 2002 | 102 | 0.040 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 337 | 0.040 |
Why?
| | Facial Neoplasms | 1 | 2001 | 19 | 0.040 |
Why?
| | Anti-Infective Agents, Local | 1 | 2001 | 40 | 0.040 |
Why?
| | Diet | 1 | 1989 | 1275 | 0.040 |
Why?
| | Salivary Gland Diseases | 1 | 2001 | 1 | 0.040 |
Why?
| | Fishes | 1 | 2001 | 108 | 0.040 |
Why?
| | AIDS Serodiagnosis | 1 | 2001 | 23 | 0.040 |
Why?
| | Melanocytes | 1 | 2001 | 65 | 0.040 |
Why?
| | Mandibular Nerve | 1 | 2000 | 5 | 0.040 |
Why?
| | Plasminogen | 1 | 2001 | 27 | 0.040 |
Why?
| | Folliculitis | 1 | 2000 | 1 | 0.040 |
Why?
| | Tooth Crown | 1 | 2000 | 2 | 0.040 |
Why?
| | Silicates | 1 | 2000 | 18 | 0.040 |
Why?
| | Liability, Legal | 1 | 2001 | 43 | 0.040 |
Why?
| | Denture, Partial, Removable | 1 | 2000 | 2 | 0.040 |
Why?
| | Time Factors | 8 | 2014 | 7183 | 0.040 |
Why?
| | Nickel | 2 | 2006 | 64 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 1989 | 1416 | 0.040 |
Why?
| | Phenols | 1 | 2001 | 114 | 0.040 |
Why?
| | Arthritis, Juvenile | 1 | 2001 | 58 | 0.040 |
Why?
| | Habits | 1 | 2000 | 52 | 0.040 |
Why?
| | Polymethacrylic Acids | 1 | 2000 | 61 | 0.040 |
Why?
| | Hodgkin Disease | 1 | 2002 | 171 | 0.040 |
Why?
| | Periodontitis | 1 | 2001 | 54 | 0.040 |
Why?
| | Alcohol Drinking | 4 | 2012 | 826 | 0.040 |
Why?
| | Smoking | 4 | 2012 | 1472 | 0.040 |
Why?
| | Diffusion | 1 | 2000 | 122 | 0.040 |
Why?
| | Emergencies | 1 | 2001 | 176 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2000 | 117 | 0.040 |
Why?
| | Silicic Acid | 1 | 2000 | 2 | 0.040 |
Why?
| | Hair | 1 | 2000 | 88 | 0.040 |
Why?
| | Complex Mixtures | 1 | 2000 | 12 | 0.040 |
Why?
| | Hyperpigmentation | 1 | 2000 | 27 | 0.040 |
Why?
| | Coloring Agents | 3 | 2012 | 93 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 164 | 0.040 |
Why?
| | Triclosan | 1 | 2000 | 9 | 0.040 |
Why?
| | Age Distribution | 3 | 2001 | 403 | 0.040 |
Why?
| | Cytomegalovirus | 2 | 1998 | 168 | 0.040 |
Why?
| | American Dental Association | 2 | 2012 | 6 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2001 | 336 | 0.040 |
Why?
| | Polymers | 2 | 2000 | 499 | 0.040 |
Why?
| | Graft Rejection | 1 | 2003 | 540 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2000 | 107 | 0.040 |
Why?
| | Survival Rate | 2 | 2002 | 2092 | 0.040 |
Why?
| | Models, Biological | 1 | 2007 | 1822 | 0.040 |
Why?
| | Nerve Block | 1 | 2000 | 103 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2002 | 444 | 0.040 |
Why?
| | Plasminogen Activators | 1 | 1998 | 7 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 168 | 0.040 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1998 | 24 | 0.040 |
Why?
| | Collagenases | 1 | 1998 | 22 | 0.040 |
Why?
| | Flavonoids | 1 | 1999 | 87 | 0.040 |
Why?
| | Herpesviridae | 1 | 1998 | 22 | 0.040 |
Why?
| | Vacuum | 1 | 1998 | 19 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2004 | 824 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2003 | 462 | 0.040 |
Why?
| | Injections, Intralesional | 2 | 1995 | 36 | 0.040 |
Why?
| | Gram-Negative Anaerobic Cocci | 1 | 1998 | 1 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2007 | 2050 | 0.040 |
Why?
| | Suction | 1 | 1998 | 33 | 0.040 |
Why?
| | Evaluation Studies as Topic | 2 | 1989 | 166 | 0.030 |
Why?
| | Virus Shedding | 1 | 1998 | 48 | 0.030 |
Why?
| | Equipment Design | 1 | 2000 | 530 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2002 | 737 | 0.030 |
Why?
| | Arteries | 1 | 2000 | 259 | 0.030 |
Why?
| | Bone Cysts | 1 | 1998 | 11 | 0.030 |
Why?
| | Periodontal Cyst | 1 | 1997 | 1 | 0.030 |
Why?
| | Fibrosarcoma | 1 | 1998 | 23 | 0.030 |
Why?
| | Eosinophilic Granuloma | 1 | 1997 | 3 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 292 | 0.030 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 1998 | 51 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 1999 | 205 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2001 | 479 | 0.030 |
Why?
| | Nose | 1 | 1998 | 68 | 0.030 |
Why?
| | Motor Skills | 1 | 1998 | 104 | 0.030 |
Why?
| | Oropharyngeal Neoplasms | 1 | 1998 | 55 | 0.030 |
Why?
| | Cytokines | 1 | 2005 | 2065 | 0.030 |
Why?
| | Incidence | 2 | 2012 | 2883 | 0.030 |
Why?
| | Temperature | 1 | 2000 | 679 | 0.030 |
Why?
| | Colony Count, Microbial | 3 | 2006 | 122 | 0.030 |
Why?
| | Survival Analysis | 1 | 2000 | 1385 | 0.030 |
Why?
| | Herpes Zoster | 1 | 2001 | 315 | 0.030 |
Why?
| | Molecular Sequence Data | 4 | 2004 | 2931 | 0.030 |
Why?
| | Periapical Granuloma | 1 | 1996 | 1 | 0.030 |
Why?
| | Radiotherapy | 1 | 1998 | 206 | 0.030 |
Why?
| | Dental Enamel Proteins | 1 | 1996 | 2 | 0.030 |
Why?
| | Role | 1 | 1996 | 29 | 0.030 |
Why?
| | Cryptococcosis | 1 | 1997 | 31 | 0.030 |
Why?
| | Digestive System | 1 | 1996 | 28 | 0.030 |
Why?
| | Growth Substances | 1 | 1996 | 140 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1996 | 16 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2003 | 704 | 0.030 |
Why?
| | Choristoma | 1 | 1996 | 21 | 0.030 |
Why?
| | Viral Proteins | 3 | 2004 | 355 | 0.030 |
Why?
| | Early Detection of Cancer | 2 | 2012 | 466 | 0.030 |
Why?
| | United States | 5 | 2012 | 15988 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 826 | 0.030 |
Why?
| | Carcinoma, Basosquamous | 1 | 1995 | 2 | 0.030 |
Why?
| | Anti-HIV Agents | 2 | 2000 | 888 | 0.030 |
Why?
| | Sarcoma, Small Cell | 1 | 1995 | 2 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1997 | 129 | 0.030 |
Why?
| | Placebos | 2 | 1986 | 193 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 1995 | 44 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1796 | 0.030 |
Why?
| | Cocarcinogenesis | 1 | 1995 | 13 | 0.030 |
Why?
| | Immunization Schedule | 1 | 1996 | 187 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1996 | 188 | 0.030 |
Why?
| | Virus Latency | 2 | 2007 | 90 | 0.030 |
Why?
| | Virus Activation | 2 | 2007 | 95 | 0.030 |
Why?
| | Hydroxyzine | 1 | 2014 | 3 | 0.030 |
Why?
| | Meperidine | 1 | 2014 | 6 | 0.030 |
Why?
| | Akathisia, Drug-Induced | 1 | 2014 | 5 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2001 | 853 | 0.030 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2014 | 14 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 36 | 0.030 |
Why?
| | Anesthesia Recovery Period | 1 | 2014 | 29 | 0.030 |
Why?
| | Pilot Projects | 3 | 2006 | 1890 | 0.030 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2157 | 0.030 |
Why?
| | Lupus Erythematosus, Discoid | 1 | 1994 | 5 | 0.030 |
Why?
| | Clobetasol | 1 | 1994 | 7 | 0.030 |
Why?
| | Genes, Viral | 2 | 2004 | 90 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 689 | 0.030 |
Why?
| | Neoplasms, Multiple Primary | 1 | 1995 | 58 | 0.030 |
Why?
| | Sleep Stages | 1 | 2014 | 75 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2000 | 8279 | 0.030 |
Why?
| | Midazolam | 1 | 2014 | 72 | 0.030 |
Why?
| | Emergency Medical Services | 1 | 2001 | 696 | 0.030 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2014 | 26 | 0.030 |
Why?
| | Adhesiveness | 1 | 1994 | 18 | 0.030 |
Why?
| | Psychomotor Agitation | 1 | 2014 | 70 | 0.030 |
Why?
| | Ketoconazole | 1 | 1993 | 3 | 0.030 |
Why?
| | Salivary Proteins and Peptides | 1 | 1993 | 14 | 0.030 |
Why?
| | Vomiting | 1 | 2014 | 130 | 0.030 |
Why?
| | Papillon-Lefevre Disease | 1 | 1993 | 1 | 0.020 |
Why?
| | Zidovudine | 1 | 1993 | 77 | 0.020 |
Why?
| | Awareness | 1 | 2014 | 110 | 0.020 |
Why?
| | Surface-Active Agents | 1 | 2014 | 92 | 0.020 |
Why?
| | Tooth Loss | 1 | 1993 | 27 | 0.020 |
Why?
| | Tolonium Chloride | 1 | 2012 | 4 | 0.020 |
Why?
| | Fibrous Dysplasia of Bone | 1 | 1991 | 5 | 0.020 |
Why?
| | Bacteria | 1 | 1998 | 889 | 0.020 |
Why?
| | Asymptomatic Diseases | 1 | 2012 | 102 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 1993 | 272 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2011 | 23 | 0.020 |
Why?
| | Control Groups | 1 | 2011 | 12 | 0.020 |
Why?
| | Dental Marginal Adaptation | 2 | 2003 | 10 | 0.020 |
Why?
| | Triamcinolone Acetonide | 1 | 1991 | 20 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1995 | 531 | 0.020 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 192 | 0.020 |
Why?
| | Physical Examination | 1 | 2012 | 240 | 0.020 |
Why?
| | Double-Blind Method | 2 | 1986 | 2029 | 0.020 |
Why?
| | Sarcoma, Ewing | 1 | 1991 | 103 | 0.020 |
Why?
| | Review Literature as Topic | 1 | 2010 | 53 | 0.020 |
Why?
| | Bias | 1 | 2011 | 202 | 0.020 |
Why?
| | RNA, Viral | 2 | 2004 | 688 | 0.020 |
Why?
| | Cell Adhesion | 2 | 2006 | 455 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 722 | 0.020 |
Why?
| | Zinc Oxide-Eugenol Cement | 1 | 1989 | 2 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2032 | 0.020 |
Why?
| | Animals | 5 | 2005 | 38109 | 0.020 |
Why?
| | Genotype | 2 | 2004 | 1835 | 0.020 |
Why?
| | Oral Hemorrhage | 2 | 2001 | 3 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 1999 | 132 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 1988 | 200 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 1998 | 415 | 0.020 |
Why?
| | Sweetening Agents | 1 | 1988 | 57 | 0.020 |
Why?
| | Mice, Nude | 2 | 1999 | 688 | 0.020 |
Why?
| | Sleep | 1 | 2014 | 901 | 0.020 |
Why?
| | Prosthodontics | 1 | 2006 | 1 | 0.020 |
Why?
| | Dentistry, Operative | 1 | 2006 | 4 | 0.020 |
Why?
| | Endodontics | 1 | 2006 | 4 | 0.020 |
Why?
| | Dental Fistula | 1 | 2006 | 1 | 0.020 |
Why?
| | Periapical Periodontitis | 1 | 2006 | 2 | 0.020 |
Why?
| | Periodontics | 1 | 2006 | 8 | 0.010 |
Why?
| | Suppositories | 1 | 1986 | 3 | 0.010 |
Why?
| | Preanesthetic Medication | 1 | 1986 | 6 | 0.010 |
Why?
| | Current Procedural Terminology | 1 | 2006 | 19 | 0.010 |
Why?
| | Fluorescent Dyes | 2 | 1998 | 330 | 0.010 |
Why?
| | Flow Cytometry | 3 | 1995 | 1173 | 0.010 |
Why?
| | Anesthesia, Local | 1 | 1986 | 25 | 0.010 |
Why?
| | Pharmaceutical Preparations | 1 | 1988 | 170 | 0.010 |
Why?
| | Amnesia | 1 | 1986 | 47 | 0.010 |
Why?
| | Cohort Studies | 2 | 2011 | 5965 | 0.010 |
Why?
| | Beryllium | 1 | 2006 | 161 | 0.010 |
Why?
| | Drug Carriers | 1 | 2006 | 130 | 0.010 |
Why?
| | Diagnosis, Oral | 1 | 2005 | 8 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 1958 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 978 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2005 | 334 | 0.010 |
Why?
| | Asthma | 1 | 1997 | 1768 | 0.010 |
Why?
| | Lung Neoplasms | 2 | 1995 | 2642 | 0.010 |
Why?
| | Immunoglobulin J-Chains | 1 | 2004 | 6 | 0.010 |
Why?
| | Lighting | 1 | 2004 | 30 | 0.010 |
Why?
| | Genes, Immunoglobulin | 1 | 2004 | 29 | 0.010 |
Why?
| | Wettability | 1 | 2004 | 15 | 0.010 |
Why?
| | Sequence Analysis | 1 | 2004 | 35 | 0.010 |
Why?
| | In Situ Hybridization | 2 | 1996 | 319 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1997 | 2171 | 0.010 |
Why?
| | Rabbits | 1 | 2005 | 648 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2007 | 4155 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2004 | 85 | 0.010 |
Why?
| | Molecular Epidemiology | 1 | 2004 | 73 | 0.010 |
Why?
| | Clone Cells | 1 | 2004 | 266 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1563 | 0.010 |
Why?
| | Connexin 26 | 1 | 2003 | 9 | 0.010 |
Why?
| | Sulfur Compounds | 1 | 2003 | 8 | 0.010 |
Why?
| | Dental Plaque Index | 1 | 2003 | 4 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 368 | 0.010 |
Why?
| | Periodontal Index | 1 | 2003 | 14 | 0.010 |
Why?
| | Mouth | 1 | 2004 | 88 | 0.010 |
Why?
| | Orthodontic Wires | 1 | 2003 | 6 | 0.010 |
Why?
| | Tooth Movement Techniques | 1 | 2003 | 13 | 0.010 |
Why?
| | Genetic Markers | 1 | 2004 | 331 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 2004 | 155 | 0.010 |
Why?
| | Breath Tests | 1 | 2003 | 79 | 0.010 |
Why?
| | Cell Count | 1 | 2004 | 321 | 0.010 |
Why?
| | Adhesives | 1 | 2003 | 15 | 0.010 |
Why?
| | Observer Variation | 1 | 2003 | 355 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2004 | 2832 | 0.010 |
Why?
| | Herpes Simplex | 1 | 2003 | 98 | 0.010 |
Why?
| | Stomatitis | 1 | 2002 | 16 | 0.010 |
Why?
| | Colorado | 2 | 1990 | 4564 | 0.010 |
Why?
| | Pigmentation Disorders | 1 | 2002 | 8 | 0.010 |
Why?
| | Longitudinal Studies | 2 | 2000 | 2947 | 0.010 |
Why?
| | Cell Movement | 1 | 2007 | 965 | 0.010 |
Why?
| | Color | 1 | 2002 | 81 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 127 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2001 | 14 | 0.010 |
Why?
| | Pigmentation | 1 | 2002 | 53 | 0.010 |
Why?
| | Toothache | 1 | 2001 | 5 | 0.010 |
Why?
| | Flatfoot | 1 | 2001 | 12 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2004 | 573 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2007 | 877 | 0.010 |
Why?
| | Blood Protein Disorders | 1 | 2001 | 1 | 0.010 |
Why?
| | Periapical Abscess | 1 | 2001 | 3 | 0.010 |
Why?
| | Erbium | 1 | 2001 | 4 | 0.010 |
Why?
| | Yttrium | 1 | 2001 | 5 | 0.010 |
Why?
| | Anti-Retroviral Agents | 1 | 2003 | 250 | 0.010 |
Why?
| | Aluminum Silicates | 1 | 2001 | 16 | 0.010 |
Why?
| | Washington | 1 | 2001 | 147 | 0.010 |
Why?
| | Dentition, Permanent | 1 | 2000 | 5 | 0.010 |
Why?
| | Conjunctivitis | 1 | 2001 | 30 | 0.010 |
Why?
| | Odds Ratio | 1 | 2003 | 1077 | 0.010 |
Why?
| | Staining and Labeling | 1 | 2001 | 151 | 0.010 |
Why?
| | Pedigree | 1 | 2001 | 514 | 0.010 |
Why?
| | Hemodynamics | 1 | 1985 | 1121 | 0.010 |
Why?
| | Cesarean Section | 1 | 2001 | 224 | 0.010 |
Why?
| | 1,2-Dipalmitoylphosphatidylcholine | 1 | 1999 | 9 | 0.010 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 1999 | 18 | 0.010 |
Why?
| | Mice | 3 | 2004 | 18365 | 0.010 |
Why?
| | Trans-Activators | 1 | 2001 | 405 | 0.010 |
Why?
| | Dentin Sensitivity | 1 | 1998 | 2 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2000 | 183 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 138 | 0.010 |
Why?
| | Scoliosis | 1 | 2001 | 224 | 0.010 |
Why?
| | Neck Muscles | 1 | 1998 | 21 | 0.010 |
Why?
| | Hematoxylin | 1 | 1998 | 8 | 0.010 |
Why?
| | Eosine Yellowish-(YS) | 1 | 1998 | 10 | 0.010 |
Why?
| | Methenamine | 1 | 1998 | 4 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1999 | 194 | 0.010 |
Why?
| | Decision Making | 1 | 2006 | 980 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1998 | 141 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 1998 | 252 | 0.010 |
Why?
| | Logistic Models | 1 | 2003 | 2119 | 0.010 |
Why?
| | Drug Resistance, Microbial | 1 | 1998 | 70 | 0.010 |
Why?
| | Point Mutation | 1 | 1999 | 243 | 0.010 |
Why?
| | Hearing Loss | 1 | 2001 | 247 | 0.010 |
Why?
| | Paraffin Embedding | 1 | 1998 | 33 | 0.010 |
Why?
| | Random Allocation | 1 | 1998 | 363 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2004 | 1496 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1998 | 269 | 0.010 |
Why?
| | Organic Chemicals | 1 | 1998 | 127 | 0.010 |
Why?
| | Mothers | 1 | 2003 | 775 | 0.010 |
Why?
| | Causalgia | 1 | 1996 | 1 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1998 | 919 | 0.010 |
Why?
| | Periodontal Ligament | 1 | 1996 | 3 | 0.010 |
Why?
| | Pneumonia, Pneumocystis | 1 | 1997 | 34 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1996 | 15 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1996 | 23 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 1998 | 529 | 0.010 |
Why?
| | Macrophages | 1 | 2004 | 1511 | 0.010 |
Why?
| | Substance Abuse, Intravenous | 1 | 1998 | 128 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1998 | 502 | 0.010 |
Why?
| | Tensile Strength | 1 | 1996 | 96 | 0.010 |
Why?
| | Syndrome | 1 | 1996 | 380 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 512 | 0.010 |
Why?
| | Digestive System Surgical Procedures | 1 | 1996 | 110 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 2609 | 0.010 |
Why?
| | Pharyngeal Neoplasms | 1 | 1995 | 4 | 0.010 |
Why?
| | Translocation, Genetic | 1 | 1995 | 118 | 0.010 |
Why?
| | Denture, Partial | 1 | 1994 | 2 | 0.010 |
Why?
| | Dental Prosthesis | 1 | 1994 | 2 | 0.010 |
Why?
| | Laryngeal Neoplasms | 1 | 1995 | 35 | 0.010 |
Why?
| | Histological Techniques | 1 | 1994 | 38 | 0.010 |
Why?
| | Phylogeny | 1 | 1999 | 1019 | 0.010 |
Why?
| | Vincristine | 1 | 1995 | 140 | 0.010 |
Why?
| | Patch Tests | 1 | 1994 | 57 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1500 | 0.010 |
Why?
| | Algorithms | 1 | 2002 | 1839 | 0.010 |
Why?
| | Aneuploidy | 1 | 1994 | 91 | 0.010 |
Why?
| | Homosexuality | 1 | 1993 | 17 | 0.010 |
Why?
| | HIV Core Protein p24 | 1 | 1993 | 32 | 0.010 |
Why?
| | Ki-1 Antigen | 1 | 1993 | 7 | 0.010 |
Why?
| | Gold | 1 | 1994 | 116 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2004 | 5997 | 0.010 |
Why?
| | Bleomycin | 1 | 1995 | 253 | 0.010 |
Why?
| | Mucins | 1 | 1993 | 76 | 0.010 |
Why?
| | Inflammation | 1 | 2004 | 2880 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1993 | 113 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2191 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 316 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1998 | 1462 | 0.010 |
Why?
| | Cell Cycle | 1 | 1995 | 597 | 0.010 |
Why?
| | Phagocytosis | 1 | 1993 | 299 | 0.010 |
Why?
| | Cell Survival | 1 | 1993 | 1098 | 0.000 |
Why?
| | Pregnancy | 1 | 2001 | 7191 | 0.000 |
Why?
| | Saccharin | 1 | 1988 | 9 | 0.000 |
Why?
| | Tablets | 1 | 1988 | 41 | 0.000 |
Why?
| | Theophylline | 1 | 1988 | 41 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1998 | 4569 | 0.000 |
Why?
| | DNA | 1 | 1994 | 1464 | 0.000 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 6053 | 0.000 |
Why?
| | Solutions | 1 | 1988 | 167 | 0.000 |
Why?
| | Sucrose | 1 | 1988 | 115 | 0.000 |
Why?
| | Neutrophils | 1 | 1993 | 1134 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1996 | 2738 | 0.000 |
Why?
| | Anticonvulsants | 1 | 1988 | 242 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1988 | 1915 | 0.000 |
Why?
|
|
Flaitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|